Opening book details…
About this Medicine article
A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence by Weber, Jeffrey; Grob, Jean-Jaques; Margolin, Kim A; Ascierto, Paolo A; Sznol, Mario; Ott, Patrick A; Lejeune, Chantal; de Pril, Veerle; Ruisi, Mary M; Hodi, F Stephen is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Weber, Jeffrey; Grob, Jean-Jaques; Margolin, Kim A; Ascierto, Paolo A; Sznol, Mario; Ott, Patrick A; Lejeune, Chantal; de Pril, Veerle; Ruisi, Mary M; Hodi, F Stephen
- Publisher
- Springer (Biomed Central Ltd.); BioMed Central; London: BioMed Central, 2013-; BMJ; Springer Science and Business Media LLC (ISSN 2051-1426)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)